跳至主要内容
临床试验/NCT07005453
NCT07005453招募中不适用

Diagnostic Performance and Sustainability of Using SCALE-EYE During Real-Time Colonoscopy

Erasmus Medical Center3 个研究点 分布在 1 个国家目标入组 241 人开始时间: 2025年9月23日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
241
试验地点
3
主要终点
SCALE-EYE diagnostic performance versus biopsy-forceps

研究概览

简要总结

A multicenter, randomized, parallel group, endoscopist blinded study to assess the diagnostic performance and sustainability of SCALE-EYE in a screening and surveillance colonoscopy population.

Sustainability will be evaluated in terms of the reduction in colonoscopies, associated waste and carbon footprint.

详细描述

Objective: This study aims to assess the diagnostic performance of SCALE-EYE in a screening and surveillance colonoscopy population. Also, sustainability of SCALE-EYE in terms of the reduction in colonoscopies, associated waste and carbon footprint is evaluated.

Study design: A multicenter, randomized, parallel group, endoscopist blinded study.

Study population: The unit of analysis is the colorectal polyp rather than the participants, approximately 289 colorectal polyps are planned to be included. Based on an expected detection rate of roughly 1.20 polyps per colonoscopy in the study population, approximately 241 participants aged 55-80 years old, who are referred for screening or surveillance colonoscopy at the participating study sites and have signed the informed consent form (ICF), will be included into the study. Polyps of all shapes (flat, sessile, pedunculated) that are found during colonoscopy and are smaller than 25 mm, as judged by the endoscopist using optical assessment, are considered eligible for inclusion.

Intervention: Participants will undergo the colonoscopy and once a colorectal polyp is identified, the polyp will first be measured by optical assessment by the endoscopist and then in a randomized order measured by biopsy-forceps assisted measurement and SCALE-EYE measurement.

Primary outcome measurement: The diagnostic performance of SCALE-EYE for polyp size categorization during real-time colonoscopy in comparison to polyp size categorization with biopsy-forceps assisted measurement (the reference standard). This will be measured by accuracy, sensitivity, and specificity of SCALE-EYE categorization compared to size measurement with the reference standard.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
Double (Participant, Care Provider)

入排标准

年龄范围
55 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Participants aged 55-80
  • •Scheduled for fecal immunochemical test (FIT) screening or surveillance colonoscopy
  • •Polyps of all forms ≤25 mm as assessed by the endoscopist

排除标准

  • •No detected colorectal polyps or only diminutive (≤5 mm) hyperplastic rectal polyps are present
  • •Inadequate bowel preparation (Boston Bowel Preparation Score (BBPS) <2 per segment)
  • •Intraprocedural complications, not caused by the study device
  • •Known or suspected inflammatory bowel disease (IBD)
  • •Polyposis syndromes (e.g. serrated polyposis, familial adenomatous polyposis)
  • •Ileoanal pouch and anastomosis
  • •History of radiation or chemotherapy for colorectal lesions
  • •Scheduled for therapeutic procedure (for example intervention to stop a lower gastro-intestinal bleeding, endoscopic mucosal resection (EMR) or endoscopic submucosal dissection (ESD))
  • •Pregnancy
  • •No Informed consent (IC) possible

研究组 & 干预措施

SCALE-EYE measurement than biopsy-forceps assisted measurement

Other

When colorectal polyps are identified, then first the polyp size is categorized by optical assessment by the endoscopist. Then the polyp size is categorized by SCALE-EYE measurement and afterwards by biopsy-forceps assisted measurement.

干预措施: SCALE-EYE (1) (Device)

Biopsy-forceps assisted measurement than SCALE-EYE measurement

Other

When colorectal polyps are identified, then first the polyp size is categorized by optical assessment by the endoscopist. Then the polyp size is categorized by biopsy-forceps assisted measurement and afterwards by SCALE-EYE measurement.

干预措施: SCALE-EYE (2) (Device)

结局指标

主要结局

SCALE-EYE diagnostic performance versus biopsy-forceps

时间窗: Immediately after the screening and/or surveillance colonoscopy

The diagnostic performance of SCALE-EYE for polyp size categorization during real-time colonoscopy in comparison to polyp size categorization with biopsy-forceps assisted measurement (the reference standard). This will be measured by accuracy, sensitivity, and specificity of SCALE-EYE categorization compared to size measurement with the reference standard.

次要结局

  • (Serious) adverse events(Up to 30 days post-colonoscopy)
  • Surveillance interval agreement(After the screening and/or surveillance colonoscopy when the endoscopist advised surveillance interval is known (on average 30 days post-colonoscopy))
  • SCALE-EYE diagnostic performance versus optical assessment(Immediately after the screening and/or surveillance colonoscopy)
  • Sustainability(After the screening and/or surveillance colonoscopy when the endoscopist advised surveillance interval is known (on average 30 days post-colonoscopy))
  • Learning curve(Immediately after the screening and/or surveillance colonoscopy)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Peter Siersema

Prof. Dr. P.D. Siersema

Erasmus Medical Center

研究点 (3)

Loading locations...

相似试验

Accuracy and Sustainability of SCALE-EYE Evaluation... | 临床试验